Compare Destinasi Tirta Nusantara Tbk (PDES) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Destinasi Tirta Nusantara Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Destinasi Tirta Nusantara Tbk trades at Rp396 (market cap 287.43B, 12.3K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 40.6× Destinasi Tirta Nusantara Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 12.3K). Which is the better fit depends on your goals.
| PDES | TSPC | |
|---|---|---|
Market Cap | 287.43B | 11.68T |
Volume | 12.3K | 429.7K |
Lot | 123 | 4.3K |
Turnover | 4.9M | 1.11B |
Average Price | 398.13 | 2,591.65 |
Value | 4.9M | 1.11B |
Indicative Equilibrium Price | 404 | 2,580 |
Indicative Equilibrium Volume | 3 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Read more on PDES →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
